Company overview
CellarisBio offers the MICRO-TAG® platform, a reagent-based technology that quantifies ligand-target engagement in real-time within intact live cells, preserving native protein context. It supports drug discovery for challenging targets like degraders, molecular glues, and covalent inhibitors by providing quantitative fluorescent readouts compatible with standard workflows. Based in San Diego, California, the company delivers reagents and collaborative solutions for precision therapeutic development.
Cellarisbio is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include cell target engagement, micro-tag platform, drug discovery assays, ligand target quantification, undruggable targets.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Cellarisbio include Assay, Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://cellarisbio.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- cell target engagement, micro-tag platform, drug discovery assays, ligand target quantification, undruggable targets
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What is the MICRO-TAG platform?
- MICRO-TAG is a cellular target engagement technology that uses enzyme complementation to convert ligand-target interactions into measurable fluorescent signals in live cells, enabling real-time, quantitative assays.
- What drug discovery applications does CellarisBio support?
- The platform targets challenging modalities including degraders, molecular glues, and covalent inhibitors, aiding target validation, de-risking, and precision therapeutic discovery across diverse programs.
- Where is CellarisBio located and what solutions do they offer?
- CellarisBio is based in San Diego, California, USA, and provides MICRO-TAG reagents, real-time assay kits, and selective collaborative programs like the Open Target Initiative for academic and industry partners.
Related editorial coverage
- Parabilis Pursues IPO After $800M Funding for Undruggable Targets
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
